Karmanos Cancer Institute, Site #034 — Detroit, Michigan

Karmanos Cancer Institute, Site #034 is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute, Site #034 has participated in 1 clinical trials.

Therapeutic areas: Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Sponsors: Ariad Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute, Site #034?

Karmanos Cancer Institute, Site #034 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute, Site #034 conducted?

Karmanos Cancer Institute, Site #034 has 1 clinical trials on record. Their work covers Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Is Karmanos Cancer Institute, Site #034 accredited by Crixeo Health?

Karmanos Cancer Institute, Site #034 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute, Site #034?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.